alemtuzumab

Ligand id: 6770

Name: alemtuzumab

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: alemtuzumab

Immunopharmacology Disease
Disease X-Refs Comment References
Relapsing-remitting multiple sclerosis Disease Ontology: DOID:2378
Approved drug for RR-MS, and controlled access for B-cell chronic lymphocytic leukemia (CLL) and transplant indications.